• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 4-/8-氨基喹啉的内酰胺和四唑的合成及体外抗原生动物评价。

Synthesis and In Vitro Antiprotozoan Evaluation of 4-/8-Aminoquinoline-based Lactams and Tetrazoles.

机构信息

School of Chemistry and Physics, University of KwaZulu Natal, Durban 4000, South Africa.

Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa.

出版信息

Molecules. 2020 Dec 15;25(24):5941. doi: 10.3390/molecules25245941.

DOI:10.3390/molecules25245941
PMID:33333924
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7765388/
Abstract

A second generation of 4-aminoquinoline- and 8-aminoquinoline-based tetrazoles and lactams were synthesized via the Staudinger and Ugi multicomponent reactions. These compounds were subsequently evaluated in vitro for their potential antiplasmodium activity against a multidrug-resistant K1 strain and for their antitrypanosomal activity against a cultured STIB900 strain. Several of these compounds (-) displayed good antiplasmodium activities (IC = 0.20-0.62 µM) that were comparable to the reference drugs, while their antitrypanosomal activity was moderate (<20 µM). Compound was 2-fold more active than primaquine and was also the most active (IC = 7.01 µM) against and also exhibited excellent aqueous solubility (>200 µM) at pH 7.

摘要

第二代基于 4-氨基喹啉和 8-氨基喹啉的四唑和内酰胺通过 Staudinger 和 Ugi 多组分反应合成。这些化合物随后在体外进行了评估,以研究它们对多药耐药 K1 株的潜在抗疟原虫活性和对 STIB900 株的抗锥虫活性。其中一些化合物(-)表现出良好的抗疟原虫活性(IC = 0.20-0.62 μM),与参考药物相当,而它们的抗锥虫活性则适中(<20 μM)。化合物比伯氨喹更具活性,对和也表现出最活跃的活性(IC = 7.01 μM),并且在 pH 7 时也表现出出色的水溶性(>200 μM)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/febb/7765388/d39510ee626c/molecules-25-05941-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/febb/7765388/dd78662065aa/molecules-25-05941-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/febb/7765388/d39510ee626c/molecules-25-05941-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/febb/7765388/dd78662065aa/molecules-25-05941-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/febb/7765388/d39510ee626c/molecules-25-05941-sch001.jpg

相似文献

1
Synthesis and In Vitro Antiprotozoan Evaluation of 4-/8-Aminoquinoline-based Lactams and Tetrazoles.基于 4-/8-氨基喹啉的内酰胺和四唑的合成及体外抗原生动物评价。
Molecules. 2020 Dec 15;25(24):5941. doi: 10.3390/molecules25245941.
2
Application of multicomponent reactions to antimalarial drug discovery. Part 2: New antiplasmodial and antitrypanosomal 4-aminoquinoline gamma- and delta-lactams via a 'catch and release' protocol.多组分反应在抗疟药物发现中的应用。第2部分:通过“捕获与释放”方案合成新型抗疟原虫和抗锥虫的4-氨基喹啉γ-和δ-内酰胺。
Bioorg Med Chem. 2006 Aug 15;14(16):5605-15. doi: 10.1016/j.bmc.2006.04.035. Epub 2006 May 11.
3
New derivatives of 7-chloroquinolin-4-amine with antiprotozoal activity.具有抗原生动物活性的7-氯喹啉-4-胺新衍生物。
Bioorg Med Chem. 2017 Feb 1;25(3):941-948. doi: 10.1016/j.bmc.2016.12.006. Epub 2016 Dec 18.
4
Antiprotozoal activity of drimane and coloratane sesquiterpenes towards Trypanosoma brucei rhodesiense and Plasmodium falciparum in vitro.针对非洲锥虫和疟原虫的瑞烷和角鲨烷倍半萜的抗原生动物活性的体外研究。
Phytother Res. 2010 Oct;24(10):1468-72. doi: 10.1002/ptr.3126.
5
Synthesis and antiprotozoal activities of benzyl phenyl ether diamidine derivatives.苯甲基苯醚二脒衍生物的合成及抗原虫活性。
Eur J Med Chem. 2013 Sep;67:310-24. doi: 10.1016/j.ejmech.2013.06.033. Epub 2013 Jun 25.
6
Antiprotozoal Activities of Tetrazole-quinolines with Aminopiperidine Linker.含氨基哌啶连接基的四唑喹啉类化合物的抗寄生虫活性
Med Chem. 2019;15(4):409-416. doi: 10.2174/1573406414666181015115101.
7
Synthesis and potent antiprotozoal activity of mono/di amidino 2-anilinobenzimidazoles versus Plasmodium falciparum and Trypanosoma brucei rhodesiense.单/二脒基-2-苯胺基苯并咪唑对恶性疟原虫和布氏罗得西亚锥虫的合成及其强效抗原虫活性
Bioorg Med Chem. 2016 Sep 15;24(18):4038-4044. doi: 10.1016/j.bmc.2016.06.047. Epub 2016 Jun 25.
8
Design, synthesis and antitrypanosomal activities of 2,6-disubstituted-4,5,7-trifluorobenzothiophenes.2,6-二取代-4,5,7-三氟苯并噻吩的设计、合成及抗锥虫活性
Eur J Med Chem. 2016 Jan 27;108:347-353. doi: 10.1016/j.ejmech.2015.11.043. Epub 2015 Nov 30.
9
Synthesis and bioevaluation of novel 4-aminoquinoline-tetrazole derivatives as potent antimalarial agents.新型 4-氨基喹啉-四唑衍生物的合成与生物评价作为有效的抗疟药物。
Eur J Med Chem. 2013 Aug;66:69-81. doi: 10.1016/j.ejmech.2013.05.023. Epub 2013 May 28.
10
Antiprotozoal activities of new bis-chlorophenyl derivatives of bicyclic octanes and aza-nonanes.双环辛烷和氮杂壬烷新型双氯苯基衍生物的抗原虫活性
Bioorg Med Chem Lett. 2006 Oct 15;16(20):5457-61. doi: 10.1016/j.bmcl.2006.07.057. Epub 2006 Aug 2.

本文引用的文献

1
The proteasome as a target for protozoan parasites.蛋白酶体作为原生动物寄生虫的靶标。
Expert Opin Ther Targets. 2019 Nov;23(11):903-914. doi: 10.1080/14728222.2019.1685981. Epub 2019 Nov 4.
2
Recent Advances in the Discovery of Novel Antiprotozoal Agents.新型抗寄生虫药物的研究进展。
Molecules. 2019 Oct 28;24(21):3886. doi: 10.3390/molecules24213886.
3
Sustainable Elimination (Zero Cases) of Sleeping Sickness: How Far Are We from Achieving This Goal?昏睡病的可持续消除(零病例):我们离实现这一目标还有多远?
Pathogens. 2019 Aug 29;8(3):135. doi: 10.3390/pathogens8030135.
4
Update on human African trypanosomiasis (sleeping sickness).更新:人类非洲锥虫病(昏睡病)。
J Neurol. 2019 Sep;266(9):2334-2337. doi: 10.1007/s00415-019-09425-7. Epub 2019 Jun 17.
5
Resolving the apparent transmission paradox of African sleeping sickness.解析非洲昏睡病的明显传播悖论。
PLoS Biol. 2019 Jan 11;17(1):e3000105. doi: 10.1371/journal.pbio.3000105. eCollection 2019 Jan.
6
Drug Discovery for Kinetoplastid Diseases: Future Directions.动质体疾病的药物发现:未来方向
ACS Infect Dis. 2019 Feb 8;5(2):152-157. doi: 10.1021/acsinfecdis.8b00298. Epub 2018 Dec 13.
7
Novel lead compounds in pre-clinical development against African sleeping sickness.处于抗非洲昏睡病临床前开发阶段的新型先导化合物。
Medchemcomm. 2017 Jul 31;8(10):1872-1890. doi: 10.1039/c7md00280g. eCollection 2017 Oct 1.
8
Human Kinetoplastid Protozoan Infections: Where Are We Going Next?人类动质体原生动物感染:我们接下来何去何从?
Front Immunol. 2018 Jul 25;9:1493. doi: 10.3389/fimmu.2018.01493. eCollection 2018.
9
Melarsoprol Resistance in African Trypanosomiasis.梅拉硫磷耐药性与非洲锥虫病。
Trends Parasitol. 2018 Jun;34(6):481-492. doi: 10.1016/j.pt.2018.04.002. Epub 2018 Apr 25.
10
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond.利用疟疾盒化合物库开展针对被忽视疾病及其他疾病的开源药物研发。
PLoS Pathog. 2016 Jul 28;12(7):e1005763. doi: 10.1371/journal.ppat.1005763. eCollection 2016 Jul.